文献速递白内障与屈光手术角膜与眼表疾病

青霉素过敏标签重分类后白内障手术前房头孢呋辛的使用

Intracameral Cefuroxime Use in Cataract Surgery After Penicillin Allergy Reclassification.
PubMed 文献 · JAMA Ophthalmol · 2026-01-01

该质量改进研究纳入美国一家大型三级眼科中心1905例有青霉素过敏标签的白内障手术患者,评估过敏标签重分类及药学支持等政策干预前后围手术期抗生素选择的变化。干预后头孢呋辛平均使用率从调整前的2%升至71%,表明基于证据的抗生素选择政策可促进前房头孢呋辛的合理使用。

要点

  • 青霉素过敏标签患者中真正过敏者不足1%,头孢菌素交叉反应风险有限。
  • 政策干预后调整后头孢呋辛使用率由2%升至71%,未调整率为80.0%。
  • 高风险过敏患者经药师审核前使用头孢呋辛的调整OR为0.37。

核心结论

  • 基于证据的抗生素选择政策可促进有青霉素过敏标签患者在白内障手术中合理使用前房头孢呋辛。

研究设计与样本

  • 质量改进研究,纳入2020年5月30日至2025年5月30日在美国一家大型三级眼科中心接受白内障手术的1905例有青霉素过敏标签患者。

主要发现

  • 1905例患者共接受3077台白内障手术,由51名外科医生完成。
  • 未调整时间序列分析中,政策干预后头孢呋辛平均使用率为80.0%(95%CI 74.5%-84.7%),远高于预期使用率3.3%(95%CI 2.0%-4.4%)(P=.001)。
  • 调整后,政策干预后头孢呋辛平均使用率为71%(95%CI 62%-79%),干预前为2%(95%CI 1%-3%)。
  • 对于病历中记录为高风险过敏(如过敏性休克或血管性水肿病史)且未经药师审核的患者,政策干预后使用头孢呋辛的调整OR为0.37(95%CI 0.27-0.52;P<.001)。

关键数值与推荐

  • 前房抗生素包括头孢呋辛1.0 mg/0.1 mL或莫西沙星0.5 mg/0.1 mL,局部抗生素包括红霉素或莫西沙星,或无预防用药。
  • 青霉素过敏标签患者中真正对青霉素过敏者不足1%。

临床怎么用

  • 对青霉素过敏标签患者,可通过药学协作和抑制电子病历交叉反应警报等措施,促进前房头孢呋辛的合理使用。
  • 外科医生可能从教育和药学支持中获益,以优化围手术期抗生素选择。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: Among patients who have a penicillin allergy label (a history of any reaction to penicillin in their medical records), many cataract surgeries are performed yearly. Less than 1% of these patients have a true allergy to penicillin. The evidence supports limited concern regarding cephalosporin cross-reactivity; however, the guidance for surgeons regarding antibiotic selection in these patients remains unclear. OBJECTIVE: To examine rates of perioperative antibiotic selection after penicillin allergy label reclassification vs before reclassification. DESIGN, SETTING, AND PARTICIPANTS: Quality improvement study including 1905 patients identified with a penicillin allergy label undergoing cataract surgery between May 30, 2020, and May 30, 2025, at a large tertiary eye care center in the US. This analysis was conducted from June 2025 to December 2025. INTERVENTION: Policy intervention for surgeons performing cataract surgery that featured enhanced pharmacy collaboration and guidance, suppression of automated electronic medical record alerts for cephalosporin cross-reactivity, and reclassification of the allergy in the medical record. The policy intervention date was set as November 30, 2022. MAIN OUTCOMES AND MEASURES: Patient receipt of intracameral antibiotics (1.0 mg/0.1 mL of cefuroxime or 0.5 mg/0.1 mL of moxifloxacin), topical antibiotics (eg, erythromycin or moxifloxacin), or no prophylaxis. Perioperative antibiotic selection rates were measured for all patients undergoing cataract surgery. RESULTS: Among the 1905 patients with a penicillin allergy label in their medical record, 3077 cataract surgeries (some patients underwent >1 cataract surgery) were performed by 51 surgeons. In an unadjusted time series analysis, the mean rate of cefuroxime use was 80.0% (95% CI, 74.5%-84.7%) after the policy intervention date, which was far above the expected use rate of 3.3% (95% CI, 2.0%-4.4%) (P = .001). After adjustment, the mean rate of cefuroxime use was 71% (95% CI, 62%-79%) after the policy intervention date compared with a mean rate of 2% (95% CI, 1%-3%) before the intervention. The adjusted odds ratio was 0.37 (95% CI, 0.27-0.52; P < .001) for cefuroxime use after the policy intervention date in patients with high-risk allergies (such as a history of anaphylaxis or angioedema) noted in the medical record and prior to review by a pharmacist. CONCLUSION AND RELEVANCE: Evidence-based antibiotic selection policies for patients with a penicillin allergy label may enhance appropriate use of intracameral cefuroxime in cataract surgery. The rapid increase in cefuroxime use after the policy intervention date suggests surgeons may benefit from education and pharmacy support.

来源:JAMA Ophthalmol,查看原文。版权归原作者所有。

引用

  1. Reddy K, Workman P, Eschenauer G, et al. Intracameral Cefuroxime Use in Cataract Surgery After Penicillin Allergy Reclassification. JAMA Ophthalmol. 2026. PMID: 41784986. doi:10.1001/jamaophthalmol.2026.0040

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。